Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
NYSE: BHVN · IEX Real-Time Price · USD
36.02
+0.04 (0.11%)
Jul 22, 2024, 10:27 AM EDT - Market open

BHVN Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Net Income
-517.18-408.17-570.28-213.8-118.67
Depreciation & Amortization
6.716.911.391.390.07
Share-Based Compensation
59.928.79193.5665.6429.5
Other Operating Activities
93.8540.7477.650.9213.14
Operating Cash Flow
-356.72-331.73-297.69-145.84-75.96
Capital Expenditures
-2.75-3.05-6.07-0.94-2.7
Acquisitions
0.390-391.880
Change in Investments
167.28132.88-259.7200
Investing Cash Flow
164.92129.83-304.790.94-2.7
Share Issuance / Repurchase
250.12247.92284.260.40
Other Financing Activities
-61.46-36.01483.34138.05152.24
Financing Cash Flow
188.66211.91767.6138.45152.24
Exchange Rate Effect
-0.52-0.50.4300
Net Cash Flow
-3.669.52165.55-6.4573.59
Free Cash Flow
-359.48-334.77-303.76-146.78-78.65
Free Cash Flow Per Share
-4.41-4.70-6.79-3.73-2.00
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).